213 related articles for article (PubMed ID: 25207654)
1. Heat shock protein 60 overexpression is associated with the progression and prognosis in gastric cancer.
Li XS; Xu Q; Fu XY; Luo WS
PLoS One; 2014; 9(9):e107507. PubMed ID: 25207654
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 22 overexpression is associated with the progression and prognosis in gastric cancer.
Li XS; Xu Q; Fu XY; Luo WS
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1305-13. PubMed ID: 24804817
[TBL] [Abstract][Full Text] [Related]
3. ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
Li XS; Xu Q; Fu XY; Luo WS
BMC Cancer; 2014 Sep; 14():705. PubMed ID: 25253129
[TBL] [Abstract][Full Text] [Related]
4. High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer.
Wang J; Cui S; Zhang X; Wu Y; Tang H
PLoS One; 2013; 8(4):e62876. PubMed ID: 23638161
[TBL] [Abstract][Full Text] [Related]
5. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ
Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958
[TBL] [Abstract][Full Text] [Related]
6. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.
Jin C; Lin JR; Ma L; Song Y; Shi YX; Jiang P; Dong Y; Li XS
Oncotarget; 2017 Feb; 8(6):10416-10424. PubMed ID: 28060752
[TBL] [Abstract][Full Text] [Related]
7. MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma.
Yao Z; Yuan T; Wang H; Yao S; Zhao Y; Liu Y; Jin S; Chu J; Xu Y; Zhou W; Yang S; Liu Y
Tumour Biol; 2017 Jun; 39(6):1010428317700411. PubMed ID: 28621235
[TBL] [Abstract][Full Text] [Related]
8. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
9. HSP60 predicts survival in advanced serous ovarian cancer.
Hjerpe E; Egyhazi S; Carlson J; Stolt MF; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
Int J Gynecol Cancer; 2013 Mar; 23(3):448-55. PubMed ID: 23429486
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
12. The tumor promoting roles of HSP60 and HIF2α in gastric cancer cells.
Tong WW; Tong GH; Kong H; Liu Y
Tumour Biol; 2016 Jul; 37(7):9849-54. PubMed ID: 26810190
[TBL] [Abstract][Full Text] [Related]
13. Expression of Vav3 protein and its prognostic value in patients with gastric cancer.
Tan B; Li Y; Shi X; Fan L; Zhao Q; Liu Y; Tan M; Liu Q; Jia N
Pathol Res Pract; 2017 May; 213(5):435-440. PubMed ID: 28285969
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
[TBL] [Abstract][Full Text] [Related]
15. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
[TBL] [Abstract][Full Text] [Related]
17. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.
Chu D; Zhang Z; Li Y; Zheng J; Dong G; Wang W; Ji G
Int J Cancer; 2011 Aug; 129(4):887-95. PubMed ID: 20957628
[TBL] [Abstract][Full Text] [Related]
19. NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9.
Chang X; Xu X; Xue X; Ma J; Li Z; Deng P; Chen J; Zhang S; Zhi Y; Dai D
Pathol Oncol Res; 2016 Oct; 22(4):789-96. PubMed ID: 27154576
[TBL] [Abstract][Full Text] [Related]
20. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
